Canada markets close in 3 hours 54 minutes

Nektar Therapeutics (NKTR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3050-0.0150 (-1.14%)
As of 12:06PM EDT. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts3344
Avg. Estimate-0.19-0.19-0.88-0.71
Low Estimate-0.22-0.22-1.21-1
High Estimate-0.17-0.15-0.65-0.31
Year Ago EPS-0.73-0.27-1.45-0.88
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts3344
Avg. Estimate15.34M15.34M67.51M62.27M
Low Estimate5.4M5.4M22.2M22.9M
High Estimate20.62M20.62M85.33M81.92M
Year Ago SalesN/A20.5M90.12M67.51M
Sales Growth (year/est)N/A-25.20%-25.10%-7.80%
Earnings History2023-03-302023-06-292023-09-292023-12-30
EPS Est.-0.25-0.28-0.2-0.21
EPS Actual-0.73-0.27-0.24-0.22
Difference-0.480.01-0.04-0.01
Surprise %-192.00%3.60%-20.00%-4.80%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.19-0.19-0.88-0.71
7 Days Ago-0.19-0.19-0.88-0.71
30 Days Ago-0.19-0.19-0.88-0.71
60 Days Ago-0.16-0.15-0.76-0.54
90 Days Ago-0.15-0.14-0.69-0.53
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNKTRIndustrySector(s)S&P 500
Current Qtr.74.00%N/AN/AN/A
Next Qtr.29.60%N/AN/AN/A
Current Year39.30%N/AN/AN/A
Next Year19.30%N/AN/AN/A
Next 5 Years (per annum)-7.30%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A